Frederick Finnegan - Chief Business Officer at SAB Biotherapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Business Officer
Stock Symbol
SABS, SABSW on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Frederick Finnegan since 9/18/2023

Holdings reported by Frederick Finnegan for SAB Biotherapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 38.6K $34K $0.88 Oct 22, 2021 Direct
Earnout Rights (Common Stock) 15.6K $18.8K $1.21 Oct 22, 2021 Direct Common Stock
Earnout Rights (Restricted Stock Units) 60.2K Oct 22, 2021 Direct Common Stock
Employee Stock Option (right to buy) 23.5K Mar 16, 2022 Direct Common Stock

Transactions reported by Frederick Finnegan for SAB Biotherapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.